McElhiney Jacqui, Drever Mathew, Lawton Linda A, Porter Andy J
School of Life Sciences, The Robert Gordon University, St. Andrew Street, Aberdeen AB25 1HG, United Kingdom.
Appl Environ Microbiol. 2002 Nov;68(11):5288-95. doi: 10.1128/AEM.68.11.5288-5295.2002.
A naïve (unimmunized) human semisynthetic phage display library was employed to isolate recombinant antibody fragments against the cyanobacterial hepatotoxin microcystin-LR. Selected antibody scFv genes were cloned into a soluble expression vector and expressed in Escherichia coli for characterization against purified microcystin-LR by competition enzyme-linked immunosorbent assay (ELISA). The most sensitive single-chain antibody (scAb) isolated was capable of detecting microcystin-LR at levels below the World Health Organization limit in drinking water (1 microg liter(-1)) and cross-reacted with three other purified microcystin variants (microcystin-RR, -LW, and -LF) and the related cyanotoxin nodularin. Extracts of the cyanobacterium Microcystis aeruginosa were assayed by ELISA, and quantifications of microcystins in toxic samples showed good correlation with analysis by high-performance liquid chromatography. Immobilized scAb was also used to prepare immunoaffinity columns, which were assessed for the ability to concentrate microcystin-LR from water for subsequent analysis by high-performance liquid chromatography. Anti-microcystin-LR scAb was immobilized on columns via a hexahistidine tag, ensuring maximum exposure of antigen binding sites, and the performance of the columns was evaluated by directly applying 150 ml of distilled water spiked with 4 micro g of purified microcystin-LR. The procedure was simple, and a recovery rate of 94% was achieved following elution in 1 ml of 100% methanol. Large-scale, low-cost production of anti-microcystin-LR scAb in E. coli is an exciting prospect for the development of biosensors and on-line monitoring systems for microcystins and will also facilitate a range of immunoaffinity applications for the cleanup and concentration of these toxins from environmental samples.
使用一个未经免疫的人源半合成噬菌体展示文库来分离针对蓝藻肝毒素微囊藻毒素-LR的重组抗体片段。将筛选出的抗体单链可变片段(scFv)基因克隆到可溶性表达载体中,并在大肠杆菌中表达,通过竞争酶联免疫吸附测定(ELISA)对纯化的微囊藻毒素-LR进行特性鉴定。分离出的最敏感的单链抗体(scAb)能够检测到低于世界卫生组织饮用水限量(1微克/升)的微囊藻毒素-LR,并且能与其他三种纯化的微囊藻毒素变体(微囊藻毒素-RR、-LW和-LF)以及相关的蓝藻毒素节球藻毒素发生交叉反应。通过ELISA对铜绿微囊藻提取物进行检测,有毒样品中微囊藻毒素的定量分析与高效液相色谱分析显示出良好的相关性。固定化的scAb还被用于制备免疫亲和柱,评估其从水中浓缩微囊藻毒素-LR以便后续进行高效液相色谱分析的能力。抗微囊藻毒素-LR的scAb通过六聚组氨酸标签固定在柱上,确保抗原结合位点最大程度暴露,通过直接向柱中加入150毫升加有4微克纯化微囊藻毒素-LR的蒸馏水来评估柱的性能。该方法简单,用1毫升100%甲醇洗脱后回收率达到94%。在大肠杆菌中大规模、低成本生产抗微囊藻毒素-LR的scAb对于开发微囊藻毒素的生物传感器和在线监测系统是一个令人兴奋的前景,也将促进一系列用于从环境样品中净化和浓缩这些毒素的免疫亲和应用。